Ptosis, ophthalmoplegia and corneal endothelial disease - ocular manifestations of mitochondrial disease
- PMID: 33869891
- PMCID: PMC8041719
- DOI: 10.1016/j.ajoc.2021.101073
Ptosis, ophthalmoplegia and corneal endothelial disease - ocular manifestations of mitochondrial disease
Abstract
Purpose: To describe two patients with bilateral ptosis, ophthalmoplegia, cataracts and corneal endothelial disease requiring corneal transplantation.
Observations: Histopathological analysis of muscle biopsy samples from both patients identified features consistent with a mitochondrial cytopathy. A single multigenic mitochondrial deoxyribonucleic acid (DNA) deletion was detected in the first patient. Pathogenic mutations in the POLG gene which codes for mitochondrial DNA polymerase, tasked with replicating the mitochondrial genome were identified in the second patient.
Conclusion: The collection of clinical features present in both cases described can be explained by a diagnosis of mitochondrial disease.
Importance: Corneal endothelial disease, in addition to ptosis, ophthalmoplegia, cataract, pigmentary retinopathy and optic atrophy should be recognised as a feature of mitochondrial disease.
Keywords: ATP, Adenosine triphosphate; CHED, Congenital hereditary endothelial dystrophy; COX, Cytochrome oxidase; CPEO, Chronic progressive external ophthalmoplegia; Corneal endothelial disease; DNA, Deoxyribonucleic acid; DSAEK, Descemet's stripping automated endothelial keratoplasty; FECD, Fuchs endothelial corneal dystrophy; LF, Levator palpebrae superioris function; MELAS syndrome, Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke; MRD1, Margin reflex 1 distance; MT-ATP6, Mitochondrially encoded adenosine triphosphate synthase membrane subunit 6; MT-TP, Mitochondrially encoded transfer ribonucleic acid proline; Mitochondrial disease; Ophthalmoplegia; Ptosis; RNA, Ribonucleic acid; SDH, Succinic dehydrogenase; TRNA, Transfer ribonucleic acid.
© 2021 The Authors.
Conflict of interest statement
The authors have no conflicts of interest to report.
Figures


References
-
- Johns D.R. Seminars in medicine of the beth Israel hospital, boston. Mitochondrial DNA and disease. N Engl J Med. 1995;333(10):638–644. - PubMed
-
- Chang T.S., Johns D.R., Stark W.J. Corneal decompensation in mitochondrial ophthalmoplegia plus (Kearns-Sayre) syndrome. A clinicopathologic case report. Cornea. 1994;13(3):269–273. - PubMed
-
- Kim J., Medsinge A., Chauhan B., Wiest C. Coenzyme Q10 in the treatment of corneal edema in kearns-sayre: is there an application in Fuchs endothelial corneal dystrophy? Cornea. 2016;35(9):1250–1254. - PubMed
-
- Kearns T.P., Sayre G.P. Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol. 1958;60(2):280–289. - PubMed
-
- Bourne W.M. Biology of the corneal endothelium in health and disease. Eye. 2003;17(8):912–918. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources